| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(04)17667-8 |
| P698 | PubMed publication ID | 15639681 |
| P50 | author | Djillali Annane | Q30004548 |
| P2093 | author name string | Eric Bellissant | |
| Jean-Marc Cavaillon | |||
| P2860 | cites work | Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach | Q78077522 |
| Nitroglycerin in septic shock after intravascular volume resuscitation | Q78494402 | ||
| Diminished interferon-gamma production and responsiveness after endotoxin administration to healthy humans | Q78560417 | ||
| Broad-range bacterial polymerase chain reaction for early detection of bacterial meningitis | Q78687297 | ||
| Protective efficacy of CAP18106-138-immunoglobulin G in sepsis | Q79238698 | ||
| Disseminated intravascular coagulation | Q93925327 | ||
| Haemophilus influenzae oral whole cell vaccination for preventing acute exacerbations of chronic bronchitis | Q24247916 | ||
| Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation | Q24338135 | ||
| Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis | Q24562848 | ||
| Science review: mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoids | Q24800806 | ||
| Early goal-directed therapy in the treatment of severe sepsis and septic shock | Q27860596 | ||
| Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group | Q28141764 | ||
| TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses | Q28177538 | ||
| Rapid up-regulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patients | Q28181010 | ||
| The dark side of C5a in sepsis | Q28252425 | ||
| Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice | Q28588786 | ||
| Tolerance, danger, and the extended family | Q29547532 | ||
| The epidemiology of sepsis in the United States from 1979 through 2000 | Q29547760 | ||
| Efficacy and safety of recombinant human activated protein C for severe sepsis | Q29547839 | ||
| Blood monocytes consist of two principal subsets with distinct migratory properties | Q29614286 | ||
| Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin | Q29615449 | ||
| The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination | Q29617876 | ||
| 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference | Q29618757 | ||
| Intensive insulin therapy in critically ill patients | Q29618795 | ||
| Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death | Q33795136 | ||
| A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin | Q33891791 | ||
| Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome | Q33892692 | ||
| Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor. | Q33894893 | ||
| Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock | Q34145159 | ||
| Paresis acquired in the intensive care unit: a prospective multicenter study | Q34163357 | ||
| Corticosteroid insufficiency in acutely ill patients | Q34178393 | ||
| Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. | Q34301553 | ||
| Measurements of serum free cortisol in critically ill patients. | Q34313649 | ||
| Should immunonutrition become routine in critically ill patients? A systematic review of the evidence | Q34339031 | ||
| Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin | Q34362734 | ||
| Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis | Q34503648 | ||
| Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial | Q34518326 | ||
| Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. | Q34535214 | ||
| A comparison of albumin and saline for fluid resuscitation in the intensive care unit | Q34548188 | ||
| Procalcitonin as a diagnostic test for sepsis: health technology assessment in the ICU. | Q35086416 | ||
| Such stuff as dreams are made on: mediator-directed therapy in sepsis | Q35128911 | ||
| Lipopolysaccharide-induced interleukin 8 production by human whole blood is enhanced by epinephrine and inhibited by hydrocortisone. | Q35549648 | ||
| Cytokine Cascade in Sepsis | Q35585026 | ||
| Hemodynamic instability in sepsis: bedside assessment by Doppler echocardiography | Q35596337 | ||
| TIR domain-containing adaptors define the specificity of TLR signaling | Q35617615 | ||
| Peptidoglycan recognition proteins (PGRPs). | Q35617624 | ||
| Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock | Q35621102 | ||
| Genomic polymorphisms in sepsis | Q35646806 | ||
| High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications | Q35652755 | ||
| Mini-review: the role of peptidoglycan recognition in innate immunity | Q35815195 | ||
| Acute renal failure and sepsis | Q35833149 | ||
| Mechanisms of immunodysregulation in sepsis. | Q35841196 | ||
| Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update | Q35877109 | ||
| Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide | Q36361146 | ||
| Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice. | Q36363402 | ||
| Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes | Q36366971 | ||
| Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia | Q37351701 | ||
| Lymphocyte subset numbers depend on the bacterial origin of sepsis | Q39074723 | ||
| Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. | Q51723077 | ||
| Aggravation of endotoxin-induced disseminated intravascular coagulation and cytokine activation in heterozygous protein-C-deficient mice. | Q52549566 | ||
| Current epidemiology of septic shock: the CUB-Réa Network. | Q53924344 | ||
| Compartmentalised inducible nitric-oxide synthase activity in septic shock. | Q54053236 | ||
| American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference | Q55879451 | ||
| Canine Endotoxin Shock: Protection against a Lethal Dose of Endotoxin following an Infusion of Histamine | Q60087831 | ||
| THE INDUCTION OF ACCELERATED THYMIC PROGRAMMED CELL DEATH DURING POLYMICROBIAL SEPSIS | Q60156973 | ||
| Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial | Q61662420 | ||
| Dissociation between plasma and monocyte-associated cytokines during sepsis | Q67969663 | ||
| Role of granulocyte elastase in tissue injury in patients with septic shock complicated by multiple-organ failure | Q68178395 | ||
| Genetic and environmental influences on premature death in adult adoptees | Q68278175 | ||
| Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin | Q68969340 | ||
| Inadequate interleukin 2 production. A fundamental immunological deficiency in patients with major burns | Q70222679 | ||
| Protective effect of recombinant neutrophil elastase inhibitor (R-020) on sepsis-induced organ injury in rat | Q71660170 | ||
| Leukocyte CD18 monoclonal antibody worsens endotoxemia and cardiovascular injury in canines with septic shock | Q72222404 | ||
| Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis | Q73024397 | ||
| Low-dose vasopressin in the treatment of vasodilatory septic shock | Q73099859 | ||
| Vasopressin deficiency contributes to the vasodilation of septic shock | Q73120268 | ||
| Prophylactic antibiotic administration reduces sepsis and mortality in acute necrotizing pancreatitis: a meta-analysis | Q73347197 | ||
| Toll-like Receptor-mediated Tumor Necrosis Factor and Interleukin-10 Production Differ during Systemic Inflammation | Q73372243 | ||
| Monocyte deactivation in septic patients: restoration by IFN-gamma treatment | Q73400029 | ||
| Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans | Q73896312 | ||
| Gene variants of the bactericidal/permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: gender-specific genetic predisposition to sepsis | Q73928186 | ||
| Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: Longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic | Q74081188 | ||
| MAPK p38 antagonism as a novel method of inhibiting lymphoid immune suppression in polymicrobial sepsis | Q74154176 | ||
| Reduced ex vivo chemokine production by polymorphonuclear cells after in vivo exposure of normal humans to endotoxin | Q74296091 | ||
| Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis | Q74539695 | ||
| Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial | Q75213817 | ||
| Tumor necrosis factor-dependent adhesions as a major protective mechanism early in septic peritonitis in mice | Q39520282 | ||
| Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock. | Q40536285 | ||
| Blocking of responses to endotoxin by E5564 in healthy volunteers with experimental endotoxemia | Q40564914 | ||
| Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms | Q40614064 | ||
| Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-DR in monocytes during septic shock | Q40624439 | ||
| The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group | Q40653300 | ||
| Protective role of phospholipid oxidation products in endotoxin-induced tissue damage | Q40706119 | ||
| CD95/CD95 ligand interactions on epithelial cells in host defense to Pseudomonas aeruginosa | Q40847899 | ||
| beta-adrenergic agonists exert their "anti-inflammatory" effects in monocytic cells through the IkappaB/NF-kappaB pathway | Q40853258 | ||
| The neurological complications of sepsis | Q40854037 | ||
| Uncoupling of biological oscillators: a complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome | Q41010995 | ||
| Efficacy of a selective histamine H2 receptor agonist, dimaprit, in experimental models of endotoxin shock and hepatitis in mice | Q42550482 | ||
| Prevention of infection in multiple trauma patients by high-dose intravenous immunoglobulins | Q43439022 | ||
| Circulating vasopressin levels in septic shock. | Q43465970 | ||
| Resistance to endotoxic shock in phospholipase A2 receptor-deficient mice | Q43479135 | ||
| NF-kappaB expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance | Q43511338 | ||
| The dynamics of disease progression in sepsis: Markov modeling describing the natural history and the likely impact of effective antisepsis agents | Q43608140 | ||
| Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock | Q43617591 | ||
| Low levels of protein C are associated with poor outcome in severe sepsis | Q43736384 | ||
| Beneficial effects of short-term vasopressin infusion during severe septic shock | Q43901842 | ||
| Adrenaline suppression of the macrophage nitric oxide response to lipopolysaccharide is associated with differential regulation of tumour necrosis factor-alpha and interleukin-10. | Q43920737 | ||
| Microvascular blood flow is altered in patients with sepsis | Q44045816 | ||
| An assessment of plasma histamine concentrations during documented endotoxic shock | Q44105028 | ||
| HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice | Q44116679 | ||
| Daily hemodialysis and the outcome of acute renal failure | Q44215628 | ||
| Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study | Q44430966 | ||
| Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial | Q44506875 | ||
| Functional alpha4-integrin: a newly identified pathway of neutrophil recruitment in critically ill septic patients | Q44537382 | ||
| Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial | Q44604894 | ||
| Increased iNOS activity is essential for intestinal epithelial tight junction dysfunction in endotoxemic mice | Q44760599 | ||
| Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol during septic shock | Q44803821 | ||
| Magnitude and duration of the effect of sepsis on survival. Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group | Q45335329 | ||
| Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group | Q46886444 | ||
| Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis | Q47238373 | ||
| CD14 receptor occupancy in severe sepsis: results of a phase I clinical trial with a recombinant chimeric CD14 monoclonal antibody (IC14). | Q47362359 | ||
| Cytokine gene promoter polymorphisms and mortality in acute renal failure | Q47909612 | ||
| Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation | Q47944753 | ||
| Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia | Q48025823 | ||
| Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock | Q48126570 | ||
| Inhibition of systemic inflammation by central action of the neuropeptide alpha-melanocyte- stimulating hormone | Q48228315 | ||
| Tumor necrosis factor-alpha contributes to apoptosis in hippocampal neurons during experimental group B streptococcal meningitis | Q48629668 | ||
| Ex vivo T-lymphocyte derived cytokine production in SIRS patients is influenced by experimental procedures. | Q51411737 | ||
| Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. | Q51639404 | ||
| P433 | issue | 9453 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | septic shock | Q1765564 |
| P304 | page(s) | 63-78 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Septic shock | |
| P478 | volume | 365 |
| Q34686193 | 'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage |
| Q28591997 | A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis |
| Q37244038 | A Non-invasive Method for Assessment of Intravascular Fluid Status: Inferior Vena Cava Diameters and Collapsibility Index |
| Q26774775 | A Review of GM-CSF Therapy in Sepsis |
| Q22306049 | A Review of the Multiple Actions of Melatonin on the Immune System |
| Q88990260 | A global perspective on vasoactive agents in shock |
| Q36088900 | A matrix metalloprotease-PAR1 system regulates vascular integrity, systemic inflammation and death in sepsis. |
| Q38586149 | A most important annexation |
| Q33970180 | A novel role of exogenous carbon monoxide on protecting cardiac function and improving survival against sepsis via mitochondrial energetic metabolism pathway |
| Q35048770 | A novel role of kukoamine B: Inhibition of the inflammatory response in the livers of lipopolysaccharide-induced septic mice via its unique property of combining with lipopolysaccharide |
| Q37332655 | A probiotic strain of Escherichia coli, Nissle 1917, given orally exerts local and systemic anti-inflammatory effects in lipopolysaccharide-induced sepsis in mice. |
| Q40543011 | A prospective treatment for sepsis |
| Q37487962 | Abdominal Septic Shock - Endotoxin Adsorption Treatment (ASSET) - endotoxin removal in abdominal and urogenital septic shock with the Alteco® LPS Adsorber: study protocol for a double-blinded, randomized placebo-controlled trial |
| Q42591237 | Acceleration of the direct identification of Staphylococcus aureus versus coagulase-negative staphylococci from blood culture material: a comparison of six bacterial DNA extraction methods. |
| Q35693793 | Actinonin, a meprin A inhibitor, protects the renal microcirculation during sepsis |
| Q41137228 | Activation of Endothelial Pro-resolving Anti-Inflammatory Pathways by Circulating Microvesicles from Non-muscular Myosin Light Chain Kinase-Deficient Mice |
| Q36177588 | Activation of innate immune genes in caprine blood leukocytes after systemic endotoxin challenge |
| Q37104028 | Acute inflammation primes myeloid effector cells for anti-inflammatory STAT6 signaling |
| Q42751548 | Adjunct therapy for sepsis: how early? |
| Q28076637 | Adrenal Gland Microenvironment and Its Involvement in the Regulation of Stress-Induced Hormone Secretion during Sepsis |
| Q40472902 | Adrenal insufficiency in severe West Nile Virus infection. |
| Q35580678 | Altered immune status of circulating T lymphocytes during sepsis: children also |
| Q47219956 | An MD2-derived peptide promotes LPS aggregation, facilitates its internalization in THP-1 cells, and inhibits LPS-induced pro-inflammatory responses |
| Q35454006 | Anthrapyrazolone analogues intercept inflammatory JNK signals to moderate endotoxin induced septic shock |
| Q39444797 | Anti-inflammatory and free radial scavenging activities of the constituents isolated from Machilus zuihoensis |
| Q37156518 | Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective |
| Q36630105 | Antibiotics for Acute Uncomplicated Diverticulitis: Time for a Paradigm Change? |
| Q89691221 | Apolipoprotein M Protects Against Lipopolysaccharide-Induced Acute Lung Injury via Sphingosine-1-Phosphate Signaling |
| Q36998459 | Are clinical trials dealing with severe infection fitting routine practices? Insights from a large registry |
| Q44021718 | Arterial blood pressure during early sepsis and outcome |
| Q60547622 | Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients |
| Q41748257 | Assessment of the pathogenesis of Streptococcus suis type 2 infection in piglets for understanding streptococcal toxic shock-like syndrome, meningitis, and sequelae |
| Q40126495 | Association Between Diabetes Mellitus and Outcomes of Patients with Sepsis: A Meta-Analysis |
| Q35690047 | Association between mannose-binding lectin deficiency and septic shock following acute pyelonephritis due to Escherichia coli |
| Q90695562 | Association of Corticosteroid Treatment With Outcomes in Adult Patients With Sepsis: A Systematic Review and Meta-analysis |
| Q37650522 | Associations among left ventricular systolic function, tachycardia, and cardiac preload in septic patients |
| Q37715085 | Automated electronic medical record sepsis detection in the emergency department. |
| Q35567163 | Availability of critical care resources to treat patients with severe sepsis or septic shock in Africa: a self-reported, continent-wide survey of anaesthesia providers |
| Q36729527 | B and T lymphocyte attenuator inhibits LPS-induced endotoxic shock by suppressing Toll-like receptor 4 signaling in innate immune cells. |
| Q29620717 | B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells |
| Q42092433 | BK large conductance Ca²+-activated K+ channel-deficient mice are not resistant to hypotension and display reduced survival benefit following polymicrobial sepsis |
| Q82138696 | Bacteremia and septic shock after solid-organ transplantation |
| Q42206362 | Bacterial RNA induces myocyte cellular dysfunction through the activation of PKR. |
| Q40439027 | Bakuchiol Protects Against Acute Lung Injury in Septic Mice |
| Q37192660 | Bench-to-bedside review: the value of cardiac biomarkers in the intensive care patient. |
| Q36987136 | Benefit-risk assessment of drotrecogin alfa (activated) in the treatment of sepsis |
| Q42969992 | Biological and hemodynamic effects of low doses of fludrocortisone and hydrocortisone, alone or in combination, in healthy volunteers with hypoaldosteronism |
| Q41488283 | Biology of immunoglobulins |
| Q36512964 | Biomarker and drug-target discovery using proteomics in a new rat model of sepsis-induced acute renal failure |
| Q35952453 | Blockade of Thrombopoietin Reduces Organ Damage in Experimental Endotoxemia and Polymicrobial Sepsis |
| Q38298664 | Blood transfusion practices in sepsis |
| Q43541174 | Bloodstream infections among human immunodeficiency virus-infected adult patients: epidemiology and risk factors for mortality |
| Q48232359 | Brain lesions in septic shock: a magnetic resonance imaging study. |
| Q41100631 | Brain-Derived Neurotrophic Factor Attenuates Septic Myocardial Dysfunction via eNOS/NO Pathway in Rats. |
| Q33694581 | CD14 inhibition efficiently attenuates early inflammatory and hemostatic responses in Escherichia coli sepsis in pigs |
| Q28282872 | CISH and susceptibility to infectious diseases |
| Q36920817 | CREB-binding protein (CBP) regulates β-adrenoceptor (β-AR)-mediated apoptosis |
| Q35889143 | Calpastatin controls polymicrobial sepsis by limiting procoagulant microparticle release |
| Q40286673 | Can procalcitonin distinguish infectious fever from tumor-related fever in non-neutropenic cancer patients? |
| Q42917023 | Can your genes make you more prone to pneumococcal disease? |
| Q36921431 | Cannabinoid receptor 2 protects against acute experimental sepsis in mice |
| Q37420143 | Carbon Monoxide Improves Efficacy of Mesenchymal Stromal Cells During Sepsis by Production of Specialized Proresolving Lipid Mediators |
| Q37061327 | Cardiac contractile reserve parameters are related to prognosis in septic shock. |
| Q48017295 | Cardiac function in Ghanaian children with severe malaria |
| Q39656776 | Cardiac isoenzymes in healthy Holstein calves and calves with experimentally induced endotoxemia. |
| Q42112600 | Cardiorenal syndromes and sepsis |
| Q38039884 | Cardiovascular management of septic shock in 2012. |
| Q54467304 | Cardiovascular protective role for activated protein C during endotoxemia in rats. |
| Q36262567 | Catecholamines-crafty weapons in the inflammatory arsenal of immune/inflammatory cells or opening pandora's box? |
| Q61767059 | Cefotaxime resistance and outcome of Klebsiella spp bloodstream infection |
| Q46827462 | Changes in plasma hormone levels following lipopolysaccharide injection in rabbits |
| Q39228127 | Chemical composition and anti-inflammatory properties of the unsaponifiable fraction from awara (Astrocaryum vulgare M.) pulp oil in activated J774 macrophages and in a mice model of endotoxic shock |
| Q34220502 | Classification of sepsis, severe sepsis and septic shock: the impact of minor variations in data capture and definition of SIRS criteria. |
| Q34194164 | Clinical characteristics and risk factors for septic shock in patients receiving emergency drainage for acute pyelonephritis with upper urinary tract calculi |
| Q34312240 | Clinical predictors and outcome of metabolic acidosis in under-five children admitted to an urban hospital in Bangladesh with diarrhea and pneumonia |
| Q34450127 | Cognitive decline after sepsis |
| Q37038749 | Commercial multiplex technologies for the microbiological diagnosis of sepsis |
| Q40690240 | Compared effects of inhibition and exogenous administration of hydrogen sulphide in ischaemia-reperfusion injury |
| Q33254339 | Comparison of severity of illness scoring systems for patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa |
| Q36489505 | Continuous hemodiafiltration with PMMA Hemofilter in the treatment of patients with septic shock |
| Q53833044 | Correlation of Procalcitonin and C-Reactive Protein with Intra-Abdominal Hypertension in Intra-Abdominal Infections: Their Predictive Role in the Progress of the Disease. |
| Q33853198 | Corticosteroid treatment for community-acquired pneumonia--the STEP trial: study protocol for a randomized controlled trial |
| Q39387531 | Corticosteroids for severe sepsis: an evidence-based guide for physicians |
| Q24187207 | Corticosteroids for treating sepsis |
| Q24247427 | Corticosteroids for treating severe sepsis and septic shock |
| Q82907081 | Cortisol levels in patients with severe community-acquired pneumonia |
| Q40281751 | Coupled Plasma Filtration Adsorption (CPFA) plus Continuous Veno-Venous Haemofiltration (CVVH) versus CVVH alone as an adjunctive therapy in the treatment of sepsis |
| Q82509197 | Current approach to the haemodynamic management of septic shock patients in European intensive care units: a cross-sectional, self-reported questionnaire-based survey |
| Q39337284 | Cytokine storm and sepsis disease pathogenesis |
| Q36925831 | Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes |
| Q34062904 | Delta neutrophil index as an early marker of disease severity in critically ill patients with sepsis. |
| Q36897188 | Depressive symptoms in spouses of older patients with severe sepsis |
| Q36877358 | Design and conduct of the activated protein C and corticosteroids for human septic shock (APROCCHSS) trial |
| Q46069635 | Determinants and Outcome of Metabolic Acidosis in Diarrheal Children Under 5 Years of Age in an Urban Critical Care Ward in Bangladesh |
| Q38845313 | Development and Implementation of Sepsis Alert Systems. |
| Q37162298 | Development of conventional and real-time multiplex PCR assays for the detection of nosocomial pathogens |
| Q35171979 | Developments for improved diagnosis of bacterial bloodstream infections. |
| Q55287384 | Diagnostic Accuracy of CD64 for Sepsis in Emergency Department. |
| Q36270469 | Diaphragmatic fatigue during sepsis and septic shock |
| Q42992410 | Did they just prove that a diagnosis of "septic shock" is meaningless? |
| Q94602033 | Difference in hematocrit and plasma albumin levels as an additional biomarker in the diagnosis of infectious disease |
| Q58786945 | Differential interactions of bacterial lipopolysaccharides with lipid membranes: implications for TRPA1-mediated chemosensation |
| Q30927749 | Direct identification of bacteria in positive blood culture bottles by matrix-assisted laser desorption ionisation time-of-flight mass spectrometry |
| Q36581909 | Distinct responses of lung and liver macrophages to acute endotoxemia: role of toll-like receptor 4. |
| Q43152135 | Does pharmacological dose of parenteral arginine have beneficial effect in rats with sub-acute peritonitis? |
| Q37133738 | Dynamics of brain natriuretic peptide in critically ill patients with severe sepsis and septic shock |
| Q35883538 | Early and dynamic changes in gene expression in septic shock patients: a genome-wide approach |
| Q34476743 | Early goal-directed therapy vs usual care in the treatment of severe sepsis and septic shock: a systematic review and meta-analysis. |
| Q30484722 | Echocardiography practice, training and accreditation in the intensive care: document for the World Interactive Network Focused on Critical Ultrasound (WINFOCUS) |
| Q55128459 | Edaravone Improves Septic Cardiac Function by Inducing an HIF-1α/HO-1 Pathway. |
| Q55093174 | Effect of Honey on Diarrhea and Fecal Microbiotain in Critically Ill Tube-Fed Patients: A Single Center Randomized Controlled Study. |
| Q47715237 | Effect of bone marrow mesenchymal stem cells on the polarization of macrophages |
| Q92889801 | Effect of sepsis on the action potential and cardiac serotonin response in rats |
| Q55293606 | Effects of Hydrocortisone on Regulating Inflammation, Hemodynamic Stability, and Preventing Shock in Severe Sepsis Patients. |
| Q47272430 | Effects of Target Temperature Management on the Outcome of Septic Patients with Fever. |
| Q51033989 | Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock. |
| Q36080700 | Effects of omega-3 fatty acid nutrition on mortality in septic patients: a meta-analysis of randomized controlled trials |
| Q40685538 | Effects of phloretin on oxidative and inflammatory reaction in rat model of cecal ligation and puncture induced sepsis |
| Q37516214 | Efficacy of coupled plasma filtration adsorption (CPFA) in patients with septic shock: a multicenter randomised controlled clinical trial |
| Q42212854 | Elevated Red Cell Distribution Width as a Prognostic Marker in Severe Sepsis: A Prospective Observational Study |
| Q36633615 | Elevated plasma levels of heparin-binding protein in intensive care unit patients with severe sepsis and septic shock |
| Q34093709 | Endogenous Tetrapyrroles Influence Leukocyte Responses to Lipopolysaccharide in Human Blood: Pre-Clinical Evidence Demonstrating the Anti-Inflammatory Potential of Biliverdin. |
| Q35956349 | Endotoxin and β-1,3-d-Glucan in Concentrated Ambient Particles Induce Rapid Increase in Blood Pressure in Controlled Human Exposures |
| Q59134292 | Enteral nutrition with omega-3 fatty acids in critically ill septic patients: A randomized double-blinded study |
| Q34644525 | Epidemic meningitis, meningococcaemia, and Neisseria meningitidis |
| Q42208310 | Epidemiology and outcome of bacteraemia in neutropenic patients in a single institution from 1991-2012. |
| Q40448497 | Epidemiology and outcome of primary community-acquired bacteremia in adult patients. |
| Q41889448 | Epidemiology, Prognosis, and Evolution of Management of Septic Shock in a French Intensive Care Unit: A Five Years Survey |
| Q48147983 | Etomidate increases susceptibility to pneumonia in trauma patients. |
| Q33422939 | Evaluating the safety and efficacy of recombinant human thrombopoietin among severe sepsis patients with thrombocytopenia: study protocol for a randomized controlled trial |
| Q91716489 | Evaluation of Continuous Renal Replacement Therapy and Therapeutic Plasma Exchange, in Severe Sepsis or Septic Shock in Critically Ill Children |
| Q49545992 | Evaluation of the Accelerate Pheno™ System: Results from Two Academic Medical Centers |
| Q42573516 | Evaluation of the BinaxNOW Staphylococcus aureus test for rapid identification of Gram-positive cocci from VersaTREK blood culture bottles |
| Q33684705 | Evaluation of the effects of ozone therapy in the treatment of intra-abdominal infection in rats |
| Q46620197 | Evaluation of the preventative effects exerted by Lactobacillus fermentum in an experimental model of septic shock induced in mice. |
| Q89533867 | Evaluation of two rapid molecular test systems to establish an algorithm for fast identification of bacterial pathogens from positive blood cultures |
| Q42953734 | Exogenous recombinant adiponectin improves survival in experimental abdominal sepsis |
| Q90296539 | Expression of Stromal Cell-Derived Factor-1 by Mesenchymal Stromal Cells Impacts Neutrophil Function During Sepsis |
| Q36005109 | Factors Associated with Streptococcal Bacteremia in Diarrheal Children under Five Years of Age and Their Outcome in an Urban Hospital in Bangladesh |
| Q90186669 | Factors associated with abnormal left ventricular ejection fraction (decreased or increased) in patients with sepsis in the intensive care unit |
| Q33666825 | Fall in circulating mononuclear cell mitochondrial DNA content in human sepsis |
| Q86002589 | Feasibility and diagnostic accuracy of early electrophysiological recordings for ICU-acquired weakness: an observational cohort study |
| Q80461728 | Ficoll-separated mononuclear cells from sepsis patients are contaminated with granulocytes |
| Q41952624 | Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis |
| Q36093621 | Fluid management and risk factors for renal dysfunction in patients with severe sepsis and/or septic shock |
| Q36879440 | Functions of the complement components C3 and C5 during sepsis |
| Q36434344 | Gastrin-releasing peptide receptor antagonism induces protection from lethal sepsis: involvement of toll-like receptor 4 signaling. |
| Q41442960 | Gene expression profiles of peripheral blood leukocytes after endotoxin challenge in humans |
| Q30980638 | Generation of anti-TLR2 intrabody mediating inhibition of macrophage surface TLR2 expression and TLR2-driven cell activation |
| Q84128506 | Gluco- and mineralocorticoid biological effects of a 7-day treatment with low doses of hydrocortisone and fludrocortisone in septic shock |
| Q41404165 | Glucocorticoids regulate the proliferation of T cells via miRNA-155 in septic shock |
| Q59804793 | Glucose variability during delirium in diabetic and non-diabetic intensive care unit patients: A prospective cohort study |
| Q37839263 | Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis |
| Q46522413 | Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. |
| Q92688331 | Harnessing the mesenchymal stem cell secretome for regenerative urology |
| Q36183586 | Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice |
| Q64928860 | High-density lipoprotein (HDL) particle size and concentration changes in septic shock patients. |
| Q34003036 | High-mobility group box-1 protein serum levels do not reflect monocytic function in patients with sepsis-induced immunosuppression |
| Q90461105 | Higher Acid-Base Imbalance Associated with Respiratory Failure Could Decrease the Survival of Patients with Scrub Typhus during Intensive Care Unit Stay: A Gene Set Enrichment Analysis |
| Q37098091 | Higher Prevalence of Klebsiella pneumoniae Extended-Spectrum β-Lactamase in Patients on Renal Replacement Therapy |
| Q83327045 | Honokiol rescues sepsis-associated acute lung injury and lethality via the inhibition of oxidative stress and inflammation |
| Q37335682 | Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis |
| Q45186970 | Human CD1c (BDCA-1)+ myeloid dendritic cells secrete IL-10 and display an immuno-regulatory phenotype and function in response to Escherichia coli. |
| Q24242859 | Human recombinant activated protein C for severe sepsis |
| Q24243896 | Human recombinant activated protein C for severe sepsis |
| Q24201123 | Human recombinant activated protein C for severe sepsis |
| Q24235181 | Human recombinant activated protein C for severe sepsis |
| Q24202128 | Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients |
| Q46973718 | Hyperreninemic hypoaldosteronism syndrome, plasma concentrations of interleukin-6 and outcome in critically ill patients with liver cirrhosis |
| Q37231853 | Hypoalbuminemia, Low Base Excess Values, and Tachypnea Predict 28-Day Mortality in Severe Sepsis and Septic Shock Patients in the Emergency Department. |
| Q87661492 | IFN-γ-producing NKT cells exacerbate sepsis by enhancing C5a generation via IL-10-mediated inhibition of CD55 expression on neutrophils |
| Q64081799 | IJV collapsibility index vs IVC collapsibility index by point of care ultrasound for estimation of CVP: a comparative study with direct estimation of CVP |
| Q36598596 | Identifying patients with severe sepsis using administrative claims: patient-level validation of the angus implementation of the international consensus conference definition of severe sepsis |
| Q36368899 | Ileus in children presenting with diarrhea and severe acute malnutrition: A chart review |
| Q38152236 | Immunopathogenesis of abdominal sepsis |
| Q39200407 | Immunostimulation using granulocyte- and granulocyte-macrophage colony stimulating factor in patients with severe sepsis and septic shock |
| Q22306306 | Immunotherapy for the Adjunctive Treatment of Sepsis: From Immunosuppression to Immunostimulation. Time for a Paradigm Change? |
| Q35595242 | Impact of ICU-acquired weakness on post-ICU physical functioning: a follow-up study |
| Q34064473 | Impact of definitive therapy with beta-lactam monotherapy or combination with an aminoglycoside or a quinolone for Pseudomonas aeruginosa bacteremia |
| Q21195133 | Impact of interleukin-10, soluble CD25 and interferon-γ on the prognosis and early diagnosis of bacteremic systemic inflammatory response syndrome: a prospective observational study |
| Q48252746 | Impact of lipopolysaccharide-induced acute inflammation on baroreflex-controlled sympathetic arterial pressure regulation |
| Q40174817 | Impact of multidetector computed tomography on the diagnosis and treatment of patients with systemic inflammatory response syndrome or sepsis. |
| Q36830961 | In vivo TLR9 inhibition attenuates CpG-induced myocardial dysfunction |
| Q35063683 | Inadequate exercise as a risk factor for sepsis mortality |
| Q92392163 | Incidence of Hypotension after Discontinuation of Norepinephrine or Arginine Vasopressin in Patients with Septic Shock: a Systematic Review and Meta-Analysis |
| Q55397222 | Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS). |
| Q79564065 | Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: the Finnsepsis study |
| Q41002132 | Increased β2-adrenergic vasorelaxation at the early phase of endotoxemic shock in rats |
| Q37725982 | Indocyanine Green-001 (ICG-001) Attenuates Wnt/β-catenin-induces Myocardial Injury Following Sepsis |
| Q33752063 | Induced expression and functional effects of aquaporin-1 in human leukocytes in sepsis |
| Q34697193 | Infection-associated clinical outcomes in hospitalized medical evacuees after traumatic injury: trauma infectious disease outcome study |
| Q37153078 | Inflammation and oxidative stress in vertebrate host-parasite systems |
| Q34026949 | Influence of genetic variations in TLR4 and TIRAP/Mal on the course of sepsis and pneumonia and cytokine release: an observational study in three cohorts |
| Q23923217 | Inhibition of MAP kinase/NF-kB mediated signaling and attenuation of lipopolysaccharide induced severe sepsis by cerium oxide nanoparticles |
| Q35378402 | Inhibition of c-Jun-N-terminal kinase increases cardiac peroxisome proliferator-activated receptor alpha expression and fatty acid oxidation and prevents lipopolysaccharide-induced heart dysfunction. |
| Q37206724 | Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsis |
| Q50951489 | Inhibition of neuronal nitric oxide synthase activity does not alter vasopressin secretion in septic rats. |
| Q40243993 | Initial patient assessment of infectious diseases and diagnostic steps with fever |
| Q37419474 | Innate immunity and inflammation--two facets of the same anti-infectious reaction. |
| Q34794590 | Insulin hypersensitivity induced by hepatic PTEN gene ablation protects from murine endotoxemia. |
| Q34697264 | Intensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock |
| Q52151934 | Interleukin-1 Receptor Antagonist Decreases Hypothalamic Oxidative Stress During Experimental Sepsis. |
| Q41691781 | Interleukin-1 receptor antagonist decreases cerebrospinal fluid nitric oxide levels and increases vasopressin secretion in the late phase of sepsis in rats. |
| Q41826464 | Interleukin-1 receptor-associated kinase M-deficient mice demonstrate an improved host defense during Gram-negative pneumonia |
| Q39197431 | Interleukin-10 gene down-expression in circulating mononuclear cells during infusion of drotrecogin-alpha activated: a pilot study |
| Q41434342 | Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis |
| Q88921640 | International Normalized Ratio Relevance to the Observed Coagulation Abnormalities in Warfarin Treatment and Disseminated Intravascular Coagulation |
| Q37026649 | Introduction of a lysine residue promotes aggregation of temporin L in lipopolysaccharides and augmentation of its antiendotoxin property |
| Q38390266 | Investigating the Impacts of Preoperative Steroid Treatment on Tumor Necrosis Factor-Alpha and Duration of Extubation Time underwent Ventricular Septal Defect Surgery. |
| Q26777818 | Is It Time to Beta Block the Septic Patient? |
| Q42714463 | Is There NO Treatment For Severe Sepsis? |
| Q36946097 | Is the septic response good or bad? |
| Q60930981 | Kidney histopathology in lethal human sepsis |
| Q42209188 | Krill Oil-In-Water Emulsion Protects against Lipopolysaccharide-Induced Proinflammatory Activation of Macrophages In Vitro |
| Q36547685 | LECT2 protects mice against bacterial sepsis by activating macrophages via the CD209a receptor |
| Q84071164 | LPS pretreatment ameliorates multiple organ injuries and improves survival in a murine model of polymicrobial sepsis |
| Q54301535 | LPS-induced effects on angiotensin I-converting enzyme expression and shedding in human pulmonary microvascular endothelial cells. |
| Q57759800 | Lack of effect of oral administration of resveratrol in LPS-induced systemic inflammation |
| Q35168957 | Lactobacillus rhamnosus GG and Bifidobacterium longum attenuate lung injury and inflammatory response in experimental sepsis |
| Q37409730 | Left atrial function for outcome prediction in severe sepsis and septic shock: an echocardiographic study. |
| Q39730337 | Leukocyte emigration in the early stages of laminitis |
| Q36035706 | Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study |
| Q33652650 | Lipid A-based affinity biosensor for screening anti-sepsis components from herbs |
| Q35221719 | Lipopolysaccharide-induced Notch signaling activation through JNK-dependent pathway regulates inflammatory response. |
| Q60547604 | Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock |
| Q56990174 | Measurement of monocytic HLA-DR (mHLA-DR) expression in patients with severe sepsis and septic shock: assessment of immune organ failure |
| Q42125266 | Mechanisms of brain signaling during sepsis |
| Q36606886 | Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis. |
| Q64057196 | Mediatory roles of leukotriene B receptors in LPS-induced endotoxic shock |
| Q36820644 | Melatonin: buffering the immune system |
| Q36609602 | Mesenchymal stromal cells improve survival during sepsis in the absence of heme oxygenase-1: the importance of neutrophils |
| Q34854364 | Methylprednisolone stiffens aortas in lipopolysaccharide-induced chronic inflammation in rats |
| Q36005391 | MicroRNA-181b regulates NF-κB-mediated vascular inflammation |
| Q57297084 | Microdialysis-Assessed Adipose Tissue Metabolism, Circulating Cytokines and Outcome in Critical Illness |
| Q46328110 | Microparticles are new biomarkers of septic shock-induced disseminated intravascular coagulopathy |
| Q39444607 | Molecular mechanisms in the pathogenesis of sepsis |
| Q34585151 | Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony |
| Q47563617 | Myocardial strain/stress changes identified by echocardiography may reveal early sepsis-induced myocardial dysfunction |
| Q31117454 | NOD2-mediated suppression of CD55 on neutrophils enhances C5a generation during polymicrobial sepsis |
| Q37729270 | Natural Killer Cell Assessment in Peripheral Circulation and Bronchoalveolar Lavage Fluid of Patients with Severe Sepsis: A Case Control Study |
| Q37959322 | Natural killer (NK) cells in antibacterial innate immunity: angels or devils? |
| Q33753792 | Neurofilaments as a plasma biomarker for ICU-acquired weakness: an observational pilot study |
| Q28080025 | New aspects in the management of pneumonia |
| Q37233599 | New strategy for sepsis: Targeting a key role of platelet-neutrophil interaction |
| Q36835542 | Nitric oxide in shock |
| Q26777554 | No Association of SERPINE1 -675 Polymorphism With Sepsis Susceptibility: A Meta-Analysis |
| Q57778873 | Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial |
| Q37106042 | Norepinephrine weaning in septic shock patients by closed loop control based on fuzzy logic |
| Q64055913 | Nuclear magnetic resonance-based serum metabolomic analysis reveals different disease evolution profiles between septic shock survivors and non-survivors |
| Q79913084 | Oral and systemic administration of beta-glucan protects against lipopolysaccharide-induced shock and organ injury in rats |
| Q58122917 | Outer Membrane Vesicles Derived From Regulate Neutrophil Migration by Induction of Endothelial IL-8 |
| Q33623708 | Outer membrane vesicles derived from Escherichia coli induce systemic inflammatory response syndrome |
| Q92001217 | Overexpression of GILZ in macrophages limits systemic inflammation while increasing bacterial clearance in sepsis in mice |
| Q34605998 | PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis |
| Q41440729 | PPAR-γ Activation Prevents Septic Cardiac Dysfunction via Inhibition of Apoptosis and Necroptosis |
| Q28592872 | Park7 interacts with p47(phox) to direct NADPH oxidase-dependent ROS production and protect against sepsis |
| Q35761448 | Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both? |
| Q35119444 | Performance of Kiestra total laboratory automation combined with MS in clinical microbiology practice |
| Q90070610 | Peroxynitrite decomposition catalyst reduces vasopressin requirement in ovine MRSA sepsis |
| Q60547646 | Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock |
| Q34510379 | Phenotype and functions of natural killer cells in critically-ill septic patients |
| Q37360321 | Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysis |
| Q56706594 | Plague |
| Q34090962 | Platelet and neutrophil responses to Gram positive pathogens in patients with bacteremic infection |
| Q33378616 | Practical aspects of treatment with drotrecogin alfa (activated) |
| Q36667000 | Preclinical investigations reveal the broad-spectrum neutralizing activity of peptide Pep19-2.5 on bacterial pathogenicity factors |
| Q46093946 | Preconditioning with ozone/oxygen mixture induces reversion of some indicators of oxidative stress and prevents organic damage in rats with fecal peritonitis |
| Q30276779 | Predicting Mortality in Low-Income Country ICUs: The Rwanda Mortality Probability Model (R-MPM). |
| Q34756833 | Predicting high vancomycin minimum inhibitory concentration in methicillin-resistant Staphylococcus aureus bloodstream infections |
| Q92436494 | Predictor of Death in Diarrheal Children Under 5 Years of Age Having Severe Sepsis in an Urban Critical Care Ward in Bangladesh |
| Q82876314 | Predictors of mortality in skin and soft-tissue infections caused by Vibrio vulnificus |
| Q33651537 | Predictors of septic shock in obstructive acute pyelonephritis |
| Q47182135 | Prescription opioids are associated with higher mortality in patients diagnosed with sepsis: A retrospective cohort study using electronic health records. |
| Q26771226 | Pressor Response to Noradrenaline in the Setting of Septic Shock: Anything New under the Sun-Dexmedetomidine, Clonidine? A Minireview |
| Q36912784 | Procalcitonin determined at emergency department as na early indicator of progression to septic shock in patient with sepsis associated with ureteral calculi |
| Q36649787 | Procalcitonin levels to guide antibiotic therapy in adults with non-microbiologically proven apparent severe sepsis: a randomised controlled trial |
| Q61368619 | Profound and persistent decrease of circulating dendritic cells is associated with ICU-acquired infection in patients with septic shock |
| Q42364000 | Prognostic Value of Venous to Arterial Carbon Dioxide Difference during Early Resuscitation in Critically Ill Patients with Septic Shock |
| Q81828641 | Prognostic value of phagocytic activity of neutrophils and monocytes in sepsis. Correlation to CD64 and CD14 antigen expression |
| Q47342010 | Propofol as a Risk Factor for ICU-Acquired Weakness in Septic Patients with Acute Respiratory Failure |
| Q42752056 | Prospective comparison of a PCR assay and a microbiological culture technique for identification of pathogens from blood and non-blood samples in septic patients |
| Q37114768 | Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4. |
| Q91638975 | Protective Effect of Melatonin Against Polymicrobial Sepsis Is Mediated by the Anti-bacterial Effect of Neutrophils |
| Q89289529 | Protective effect of Xuebijing injection on myocardial injury in patients with sepsis: a randomized clinical trial |
| Q54548201 | Protein C -1641A/-1654C haplotype is associated with organ dysfunction and the fatal outcome of severe sepsis in Chinese Han population. |
| Q58957239 | Protein C promoter polymorphisms associate with sepsis in children with systemic meningococcemia |
| Q35758679 | Protein Phosphatase 2A in Lipopolysaccharide-Induced Cyclooxygenase-2 Expression in Murine Lymphatic Endothelial Cells |
| Q95840689 | Qiang Xin 1 Formula Suppresses Excessive Pro-Inflammatory Cytokine Responses and Microglia Activation to Prevent Cognitive Impairment and Emotional Dysfunctions in Experimental Sepsis |
| Q36564435 | ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression |
| Q41783624 | Rapid detection of Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) in wound specimens and blood cultures: multicenter preclinical evaluation of the Cepheid Xpert MRSA/SA skin and soft tissue and blood culture assays |
| Q80762609 | Rapid detection of methicillin-resistant staphylococci by real-time PCR directly from positive blood culture bottles |
| Q41908737 | Rapid identification of Staphylococcus aureus directly from Bactec blood culture broth by the BinaxNOW S. aureus test |
| Q42537154 | Rapid identification of Staphylococcus aureus in blood cultures by a combination of fluorescence in situ hybridization using peptide nucleic acid probes and flow cytometry |
| Q33632929 | Rapid identification of bacterial pathogens in positive blood culture bottles by use of a broad-based PCR assay coupled with high-resolution melt analysis |
| Q37504210 | Real-time PCR TaqMan assay for rapid screening of bloodstream infection |
| Q27002436 | Recent advances in the diagnosis and management of cirrhosis-associated cardiomyopathy in liver transplant candidates: advanced echo imaging, cardiac biomarkers, and advanced heart failure therapies |
| Q40502089 | Red cell distribution width and early mortality in elderly patients with severe sepsis and septic shock |
| Q33916964 | Regulation of heme oxygenase-1 gene by peptidoglycan involves the interaction of Elk-1 and C/EBPalpha to increase expression |
| Q35691303 | Relationships between genetic polymorphisms of triggering receptor expressed on myeloid cells-1 and septic shock in a Chinese Han population |
| Q39401000 | Relative Bradycardia in Patients With Septic Shock Requiring Vasopressor Therapy |
| Q36417154 | Remifentanil : a review of its analgesic and sedative use in the intensive care unit |
| Q58776493 | Responses of Transgenic Melatonin-Enriched Goats on LPS Stimulation and the Proteogenomic Profiles of Their PBMCs |
| Q34042732 | Resuscitation after cardiac arrest in a septic porcine model: adding vasopressin vs epinephrine alone administration |
| Q34031614 | Risk factors for death after sepsis in patients immunosuppressed before the onset of sepsis |
| Q41095267 | Risk factors for sepsis in Korean trauma patients. |
| Q93136088 | Robustness of sepsis-3 criteria in critically ill patients |
| Q46003435 | Role of T cells in a murine model of Escherichia coli sepsis. |
| Q34822668 | Role of haem oxygenase-1 in microbial host defence |
| Q37619436 | Role of miR-181 family in regulating vascular inflammation and immunity |
| Q36227219 | SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance |
| Q41894219 | Sedation improves early outcome in severely septic Sprague Dawley rats |
| Q37787088 | Sensory circumventricular organs in health and disease |
| Q37256595 | Sepsis and septic shock: progress and future considerations |
| Q90776878 | Sepsis is associated with lack of monocyte HLA-DR expression recovery without modulating T-cell reconstitution after lung transplantation |
| Q59980817 | Sepsis-associated cardiac dysfunction is controlled by small RNA molecules |
| Q39167276 | Sepsis-induced cardiac dysfunction and β-adrenergic blockade therapy for sepsis. |
| Q35687065 | Sepsis-induced cardiomyopathy |
| Q26751572 | Sepsis-induced myocardial dysfunction: pathophysiology and management |
| Q33401213 | Septic shock and chemotherapy-induced cytopenia: effects on microcirculation |
| Q36126723 | Severe Sepsis in Severely Malnourished Young Bangladeshi Children with Pneumonia: A Retrospective Case Control Study |
| Q91551902 | Shenfu injection attenuates lipopolysaccharide-induced myocardial inflammation and apoptosis in rats |
| Q40052222 | Sirtuin 2 Deficiency Increases Bacterial Phagocytosis by Macrophages and Protects from Chronic Staphylococcal Infection |
| Q42936851 | Skeletal Muscle and Lymphocyte Mitochondrial Dysfunctions in Septic Shock Trigger ICU-Acquired Weakness and Sepsis-Induced Immunoparalysis. |
| Q34281893 | Soluble ST2 in the fetal inflammatory response syndrome: in vivo evidence of activation of the anti-inflammatory limb of the immune response |
| Q60547640 | Statins and sepsis: do we really need to further decrease monocyte HLA-DR expression to treat septic patients? |
| Q36369699 | Statins in the critically ill |
| Q39630800 | Stimulation of Alpha7 Nicotinic Acetylcholine Receptor by Nicotine Attenuates Inflammatory Response in Macrophages and Improves Survival in Experimental Model of Sepsis Through Heme Oxygenase-1 Induction |
| Q36743342 | Streptococcus suis: an emerging zoonotic pathogen |
| Q33707687 | Suppressing an anti-inflammatory cytokine reveals a strong age-dependent survival cost in mice |
| Q37272328 | Suppression of PTRF alleviates the polymicrobial sepsis induced by cecal ligation and puncture in mice |
| Q57686220 | Symptoms of Depression in Survivors of Severe Sepsis |
| Q34337900 | Symptoms of depression in survivors of severe sepsis: a prospective cohort study of older Americans |
| Q46602287 | Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists |
| Q43102393 | Systemic corticosteroids and community-acquired pneumonia-cautious optimism or wishful thinking? |
| Q92434278 | Systemic infection and microglia activation: a prospective postmortem study in sepsis patients |
| Q34255776 | TLR2 stimulation induces cardiac inflammation but not cardiac depression in vivo |
| Q36851875 | TLR4-induced IFN-gamma production increases TLR2 sensitivity and drives Gram-negative sepsis in mice |
| Q37078482 | Targeting RAGE in sepsis |
| Q64064138 | Targeting the Blood-Brain Barrier to Prevent Sepsis-Associated Cognitive Impairment |
| Q92535791 | Terlipressin Versus Norepinephrine for Septic Shock: A Systematic Review and Meta-Analysis |
| Q34325901 | Thaliporphine preserves cardiac function of endotoxemic rabbits by both directly and indirectly attenuating NFκB signaling pathway. |
| Q92105114 | The Elabela-APJ axis: a promising therapeutic target for heart failure |
| Q37219410 | The Methanol Extract of Azadirachta indica A. Juss Leaf Protects Mice Against Lethal Endotoxemia and Sepsis |
| Q26744591 | The Role of ACTH and Corticosteroids for Sepsis and Septic Shock: An Update |
| Q91599143 | The Value of Decreased Thyroid Hormone for Predicting Mortality in Adult Septic Patients: A Systematic Review and Meta-Analysis |
| Q36546390 | The activation of EGFR promotes myocardial tumor necrosis factor-α production and cardiac failure in endotoxemia |
| Q37419567 | The adenosine A₂A receptor - myocardial protectant and coronary target in endotoxemia |
| Q37285065 | The antifungal agent itraconazole induces the accumulation of high mannose glycoproteins in macrophages |
| Q47653604 | The apelinergic system as an alternative to catecholamines in low-output septic shock |
| Q47602497 | The biology of natural killer cells during sepsis. |
| Q41194878 | The bridge stent technique for salvage of pancreaticojejunal anastomotic dehiscence |
| Q36025227 | The causes and treatment outcomes of 91 patients with adult nosocomial meningitis |
| Q26997798 | The effect of goal-directed therapy on mortality in patients with sepsis - earlier is better: a meta-analysis of randomized controlled trials |
| Q42321768 | The effects of moderate-dose steroid therapy in sepsis: A placebo-controlled, randomized study. |
| Q34586566 | The epidemiology, antifungal use and risk factors of death in elderly patients with candidemia: a multicentre retrospective study |
| Q44587821 | The immunomodulatory properties of viable Lactobacillus salivarius ssp. salivarius CECT5713 are not restricted to the large intestine. |
| Q37592518 | The impact of hydrocortisone treatment on neutrophil gelatinase-associated lipocalin release in porcine endotoxemic shock |
| Q98568308 | The potential role of pneumococcal conjugate vaccine in reducing acute respiratory inflammation in community-acquired pneumococcal pneumonia |
| Q28395036 | The presence of 3-hydroxy oxylipins in pathogenic microbes |
| Q41777501 | The prognostic value of atrial and brain natriuretic peptides, troponin I and C-reactive protein in patients with sepsis |
| Q46183220 | The role of hypercytokinemia in the pathophysiology of tumor lysis syndrome (TLS) and the treatment with continuous hemodiafiltration using a polymethylmethacrylate membrane hemofilter (PMMA-CHDF). |
| Q37883097 | The role of natural killer cells in sepsis |
| Q37270943 | The stressed host response to infection: the disruptive signals and rhythms of systemic inflammation |
| Q64097459 | The value of the neutrophil-lymphocyte count ratio in the diagnosis of sepsis in patients admitted to the Intensive Care Unit: A retrospective cohort study |
| Q35040409 | Thirst perception and osmoregulation of vasopressin secretion are altered during recovery from septic shock |
| Q33437851 | Thrombocytopaenia during methicillin-sensitive Staphylococcus aureus bacteraemia |
| Q33395120 | Thrombocytopenia in Staphylococcus aureus bacteremia: risk factors and prognostic importance |
| Q47096499 | Thrombomodulin favors leukocyte microvesicle fibrinolytic activity, reduces NETosis and prevents septic shock-induced coagulopathy in rats. |
| Q33822349 | Timing of vasopressor initiation and mortality in septic shock: a cohort study |
| Q46831536 | Tissue-type plasminogen activator regulates macrophage activation and innate immunity. |
| Q40344306 | Toxic shock syndrome (TSS) after a postsurgery knee infection |
| Q29248526 | Transcriptomic meta-analysis reveals up-regulation of gene expression functional in osteoclast differentiation in human septic shock |
| Q40582390 | Tsr Chemoreceptor Interacts With IL-8 Provoking E. coli Transmigration Across Human Lung Epithelial Cells |
| Q47133536 | Unfractionated heparin protects the protein C system against lipopolysaccharide-induced damage in vivo and in vitro |
| Q28221646 | Unraveling the lethal synergism between Trypanosoma cruzi infection and LPS: a role for increased macrophage reactivity |
| Q34043807 | Use of n-3 PUFAs can decrease the mortality in patients with systemic inflammatory response syndrome: a systematic review and meta-analysis |
| Q37279882 | Using surface molecule expression on lymphocytes to classify septic shock patients |
| Q38755878 | Utilizing melatonin to combat bacterial infections and septic injury. |
| Q36461468 | Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity. |
| Q92863246 | Value of dynamic plasma cell-free DNA monitoring in septic shock syndrome: A case report |
| Q44111786 | Vascular ATP-sensitive potassium channels are over-expressed and partially regulated by nitric oxide in experimental septic shock |
| Q37791460 | Vascular hyporesponsiveness to vasopressors in septic shock: from bench to bedside |
| Q48247612 | Vasoplegia in patients with sepsis and septic shock: pathways and mechanisms |
| Q40968473 | Very high volume hemofiltration with the Cascade system in septic shock patients |
| Q41835917 | Why a second look might be worth it: immuno-modulatory therapies in the critically ill patient |
| Q35795306 | Year in review in Intensive Care Medicine 2011: I. Nephrology, epidemiology, nutrition and therapeutics, neurology, ethical and legal issues, experimentals. |
| Q80501976 | [Blockage of potassium channels in septic shock, another lost hope?] |
| Q96812208 | [From sepsis to septic shock] |
| Q87164845 | [Intensive care unit acquired weakness. Pathogenesis, treatment, rehabilitation and outcome] |
| Q82893761 | [Non-infective treatments for septic shock] |
| Q87362767 | [Use of biomarkers in sepsis. Update and perspectives] |
| Q58700395 | miR-146a Attenuates Sepsis-Induced Myocardial Dysfunction by Suppressing IRAK1 and TRAF6 via Targeting ErbB4 Expression |
Search more.